Insider Trading › EXAS › Insiders
EXAS
EXAS·Insider activity
—
No end-of-day price on record
EXAS
Insider purchases and sales on the price
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
EXASS&P 500 (rebased)
Insider BuyInsider SellForm 144 · planned sale
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
No open-market insider purchases or sales of EXAS were filed in the last 180 days. Newest filing Nov 21, 2025 (10 months ago).
Net Insider Buying by Quarter
Shares bought (+) or sold (−) on the open market by EXAS insiders · Form 4 · last two years
On Record
$0Purchases · 180 days
$0Sales · 180 days
501Open-market transactions on record
0Insiders filing · 180 days
Purchases (code P) and sales (code S) of EXAS common stock reported on Form 4, with Form 5 annual catch-ups. Grants, option exercises, gifts and tax withholding are not shown. Dollars are shares × the stated price; a price outside anything the stock traded at that day is withheld (n/c).
Insider Transactions
501 on record · newest trade first · the newest 300 shown
AllPurchasesSalesOfficers & directors
| Insider | Type | Shares | Price | Value | Held after | Traded | Filed | |
|---|---|---|---|---|---|---|---|---|
| ORVILLE JACOB AEVP, GM, Screening | Sale | −5,000 | $75.00 | $375K | 23.2Kdirect | Nov 19, 2025 | Nov 21, 2025 | Form 4 ↗ |
| Herriott JamesSVP, General Counsel & Sec | Sale | −1,000 | $70.00 | $70K | 11.6Kdirect | Nov 19, 2025 | Nov 21, 2025 | Form 4 ↗ |
| Herriott JamesSVP, General Counsel & Sec | Sale | −1,500 | $70.08 | $105K | 12.6Kdirect | Nov 4, 2025 | Nov 6, 2025 | Form 4 ↗ |
| Baranick BrianEVP, GM, Precision Oncology | Sale | −2,858 | $70.08 | $200K | 22.4Kdirect | Nov 4, 2025 | Nov 6, 2025 | Form 4 ↗ |
| Zanotti Katherine SDirector | Sale | −12.0K | $65.00 | $780K | 60.8Kdirect | Oct 24, 2025 | Oct 27, 2025 | Form 4 ↗ |
| Herriott JamesSVP, General Counsel & Sec | Sale | −1,500 | $60.00 | $90K | 14.1Kdirect | Oct 9, 2025 | Oct 10, 2025 | Form 4 ↗ |
| Doyle James EdwardDirector | Sale | −2,000 | $60.00 | $120K | 58.0Kdirect | Oct 9, 2025 | Oct 10, 2025 | Form 4 ↗ |
| Doyle James EdwardDirector | Sale | −1,485 | $42.02 | $62K | 60.0Kdirect | Aug 13, 2025 | Aug 14, 2025 | Form 4 ↗ |
| Zanotti Katherine SDirector | Sale | −3,207 | $53.20 | $171K | 72.8Kdirect | Jun 13, 2025 | Jun 16, 2025 | Form 4 ↗ |
| Conroy Kevin TPresident and CEO · Director | Purchase | +19.5K | $51.35 | $1.0M | 1.1Mdirect | Nov 13, 2024 | Nov 13, 2024 | Form 4 ↗ |
| Baranick BrianEVP, GM, Precision Oncology | Sale | −929 | $70.00 | $65K | 12.8Kdirect | Oct 8, 2024 | Oct 9, 2024 | Form 4 ↗ |
| Baranick BrianEVP, GM, Precision Oncology | Sale | −929 | $70.00 | $65K | 13.7Kdirect | Sep 18, 2024 | Sep 19, 2024 | Form 4 ↗ |
| COWARD D SCOTTDirector | Sale | −67 | $60.15 | $4K | 44.6Kdirect | May 1, 2024 | May 2, 2024 | Form 4 ↗ |
| Cunningham EverettChief Commercial Officer | Sale | −136 | $60.15 | $8K | 47.0Kdirect | May 1, 2024 | May 2, 2024 | Form 4 ↗ |
| Herriott JamesSVP, General Counsel & Sec | Sale | −30 | $60.15 | $2K | 9,866direct | May 1, 2024 | May 2, 2024 | Form 4 ↗ |
| Conroy Kevin TPresident and CEO · Director | Sale | −1,155 | $60.15 | $69K | 1.2Mdirect | May 1, 2024 | May 2, 2024 | Form 4 ↗ |
| ORVILLE JACOB AGeneral Manager, Screening | Sale | −102 | $60.15 | $6K | 14.4Kdirect | May 1, 2024 | May 2, 2024 | Form 4 ↗ |
| Baranick BrianEVP, GM., Precision Oncology | Sale | −110 | $60.15 | $7K | 13.3Kdirect | May 1, 2024 | May 2, 2024 | Form 4 ↗ |
| Condella SarahEVP, Human Resources | Sale | −102 | $60.15 | $6K | 72.6Kdirect | May 1, 2024 | May 2, 2024 | Form 4 ↗ |
| Elliott Jeffrey ThomasChief Financial Officer | Sale | −136 | $60.15 | $8K | 11.8Kdirect | May 1, 2024 | May 2, 2024 | Form 4 ↗ |
| Baranick BrianEVP, GM., Precision Oncology | Sale | −924 | $79.43 | $73K | 13.2Kdirect | Apr 2, 2024 | Apr 3, 2024 | Form 4 ↗ |
| Condella SarahEVP, Human Resources | Sale | −2,000 | $70.00 | $140K | 71.8Kdirect | Apr 1, 2024 | Apr 3, 2024 | Form 4 ↗ |
| Condella SarahEVP, Human Resources | Sale | −2,000 | $70.00 | $140K | 73.8Kdirect | Mar 28, 2024 | Apr 1, 2024 | Form 4 ↗ |
| ORVILLE JACOB AGeneral Manager, Screening | Sale | −2,154 | $59.32 | $128K | 14.3Kdirect | Mar 1, 2024 | Mar 4, 2024 | Form 4 ↗ |
| LEVANGIE DANIEL JDirector | Sale | −5,000 | $57.50 | $288K | 23.0Kdirect | Mar 1, 2024 | Mar 4, 2024 | Form 4 ↗ |
| Herriott JamesGeneral Counsel | Sale | −862 | $59.32 | $51K | 9,125direct | Mar 1, 2024 | Mar 4, 2024 | Form 4 ↗ |
| Elliott Jeffrey ThomasChief Financial Officer | Sale | −2,412 | $59.32 | $143K | 10.9Kdirect | Mar 1, 2024 | Mar 4, 2024 | Form 4 ↗ |
| Doyle James EdwardDirector | Sale | −2,000 | $57.50 | $115K | 50.1Kdirect | Mar 1, 2024 | Mar 4, 2024 | Form 4 ↗ |
| Cunningham EverettChief Commercial Officer | Sale | −2,412 | $59.32 | $143K | 46.2Kdirect | Mar 1, 2024 | Mar 4, 2024 | Form 4 ↗ |
| Conroy Kevin TPresident and CEO · Director | Sale | −8,271 | $59.32 | $491K | 1.3Mdirect | Mar 1, 2024 | Mar 4, 2024 | Form 4 ↗ |
| Condella SarahEVP, Human Resources | Sale | −1,724 | $59.32 | $102K | 75.8Kdirect | Mar 1, 2024 | Mar 4, 2024 | Form 4 ↗ |
| Baranick BrianGen. Mgr., Precision Oncology | Sale | −2,323 | $59.32 | $138K | 14.1Kdirect | Mar 1, 2024 | Mar 4, 2024 | Form 4 ↗ |
| ORVILLE JACOB AGeneral Manager, Screening | Sale | −1,879 | $56.89 | $107K | 11.8Kdirect | Feb 27, 2024 | Feb 28, 2024 | Form 4 ↗ |
| Herriott JamesGeneral Counsel | Sale | −784 | $56.89 | $45K | 8,097direct | Feb 27, 2024 | Feb 28, 2024 | Form 4 ↗ |
| Cunningham EverettChief Commercial Officer | Sale | −3,648 | $56.89 | $208K | 43.3Kdirect | Feb 27, 2024 | Feb 28, 2024 | Form 4 ↗ |
| Elliott Jeffrey ThomasChief Financial Officer | Sale | −2,710 | $56.89 | $154K | 8,054direct | Feb 27, 2024 | Feb 28, 2024 | Form 4 ↗ |
| Conroy Kevin TPresident and CEO · Director | Sale | −6,263 | $56.89 | $356K | 1.3Mdirect | Feb 27, 2024 | Feb 28, 2024 | Form 4 ↗ |
| Condella SarahEVP, Human Resources | Sale | −1,880 | $56.89 | $107K | 73.7Kdirect | Feb 27, 2024 | Feb 28, 2024 | Form 4 ↗ |
| Baranick BrianGen. Mgr., Precision Oncology | Sale | −2,027 | $56.89 | $115K | 11.7Kdirect | Feb 27, 2024 | Feb 28, 2024 | Form 4 ↗ |
| Condella SarahEVP, Human Resources | Sale | −1,021 | $59.72 | $61K | 71.7Kdirect | Feb 23, 2024 | Feb 26, 2024 | Form 4 ↗ |
| ORVILLE JACOB AGeneral Manager, Screening | Sale | −1,013 | $59.78 | $61K | 9,679direct | Feb 22, 2024 | Feb 23, 2024 | Form 4 ↗ |
| Herriott JamesGeneral Counsel | Sale | −291 | $59.78 | $17K | 7,233direct | Feb 22, 2024 | Feb 23, 2024 | Form 4 ↗ |
| Elliott Jeffrey ThomasChief Financial Officer | Sale | −1,351 | $59.78 | $81K | 5,063direct | Feb 22, 2024 | Feb 23, 2024 | Form 4 ↗ |
| Cunningham EverettChief Commercial Officer | Sale | −1,350 | $59.78 | $81K | 39.3Kdirect | Feb 22, 2024 | Feb 23, 2024 | Form 4 ↗ |
| COWARD D SCOTTDirector | Sale | −663 | $59.78 | $40K | 44.5Kdirect | Feb 22, 2024 | Feb 23, 2024 | Form 4 ↗ |
| Conroy Kevin TPresident and CEO · Director | Sale | −11.6K | $59.78 | $691K | 1.2Mdirect | Feb 22, 2024 | Feb 23, 2024 | Form 4 ↗ |
| Condella SarahEVP, Human Resources | Sale | −1,013 | $59.78 | $61K | 72.7Kdirect | Feb 22, 2024 | Feb 23, 2024 | Form 4 ↗ |
| Baranick BrianGen. Mgr., Precision Oncology | Sale | −1,093 | $59.78 | $65K | 9,767direct | Feb 22, 2024 | Feb 23, 2024 | Form 4 ↗ |
| ORVILLE JACOB AGeneral Manager, Screening | Sale | −1,078 | $61.50 | $66K | 8,658direct | Feb 21, 2024 | Feb 22, 2024 | Form 4 ↗ |
| Herriott JamesGeneral Counsel | Sale | −415 | $61.50 | $26K | 6,943direct | Feb 21, 2024 | Feb 22, 2024 | Form 4 ↗ |
| Elliott Jeffrey ThomasChief Financial Officer | Sale | −1,493 | $61.50 | $92K | 3,703direct | Feb 21, 2024 | Feb 22, 2024 | Form 4 ↗ |
| COWARD D SCOTTDirector | Sale | −706 | $61.50 | $43K | 43.1Kdirect | Feb 21, 2024 | Feb 22, 2024 | Form 4 ↗ |
| Conroy Kevin TPresident and CEO · Director | Sale | −4,975 | $61.50 | $306K | 1.2Mdirect | Feb 21, 2024 | Feb 22, 2024 | Form 4 ↗ |
| Condella SarahEVP, Human Resources | Sale | −1,079 | $61.50 | $66K | 71.7Kdirect | Feb 21, 2024 | Feb 22, 2024 | Form 4 ↗ |
| Baranick BrianGen. Mgr., Precision Oncology | Sale | −895 | $61.50 | $55K | 8,826direct | Feb 21, 2024 | Feb 22, 2024 | Form 4 ↗ |
| ORVILLE JACOB AGeneral Manager, Screening | Sale | −966 | $61.43 | $59K | 7,488direct | Feb 15, 2024 | Feb 16, 2024 | Form 4 ↗ |
| Herriott JamesGeneral Counsel | Sale | −421 | $61.43 | $26K | 6,494direct | Feb 15, 2024 | Feb 16, 2024 | Form 4 ↗ |
| Elliott Jeffrey ThomasChief Financial Officer | Sale | −1,888 | $61.43 | $116K | 2,084direct | Feb 15, 2024 | Feb 16, 2024 | Form 4 ↗ |
| COWARD D SCOTTDirector | Sale | −1,376 | $61.43 | $85K | 41.6Kdirect | Feb 15, 2024 | Feb 16, 2024 | Form 4 ↗ |
| Conroy Kevin TPresident and CEO · Director | Sale | −14.8K | $61.43 | $909K | 1.2Mdirect | Feb 15, 2024 | Feb 16, 2024 | Form 4 ↗ |
| Condella SarahEVP, Human Resources | Sale | −965 | $61.43 | $59K | 70.5Kdirect | Feb 15, 2024 | Feb 16, 2024 | Form 4 ↗ |
| Condella SarahEVP, Human Resources | Sale | −2,000 | $73.50 | $147K | 69.4Kdirect | Jan 2, 2024 | Jan 4, 2024 | Form 4 ↗ |
| Baranick BrianGen. Mgr., Precision Oncology | Sale | −879 | $73.50 | $65K | 7,992direct | Jan 2, 2024 | Jan 4, 2024 | Form 4 ↗ |
| Condella SarahEVP, Human Resources | Sale | −2,000 | $70.00 | $140K | 71.4Kdirect | Dec 14, 2023 | Dec 18, 2023 | Form 4 ↗ |
| Cunningham EverettChief Commercial Officer | Sale | −13.0K | $66.49 | $865K | 37.9Kdirect | Oct 12, 2023 | Oct 13, 2023 | Form 4 ↗ |
| Condella SarahEVP, Human Resources | Sale | −4,500 | $84.36 | $380K | 75.8Kdirect | Sep 1, 2023 | Sep 6, 2023 | Form 4 ↗ |
| Elliott Jeffrey ThomasChief Financial Officer | Sale | −30.2K | $82.92 | $2.5M | 0direct | Aug 21, 2023 | Aug 23, 2023 | Form 4 ↗ |
| Baranick BrianGen. Mgr., Precision Oncology | Sale | −1,350 | $85.04 | $115K | 8,871direct | Aug 7, 2023 | Aug 8, 2023 | Form 4 ↗ |
| Doyle James EdwardDirector | Sale | −2,000 | $97.42 | $195K | 52.1Kdirect | Jul 27, 2023 | Jul 28, 2023 | Form 4 ↗ |
| Herriott JamesGeneral Counsel | Sale | −1,300 | $100.00 | $130K | 5,964direct | Jul 19, 2023 | Jul 21, 2023 | Form 4 ↗ |
| Doyle James EdwardDirector | Sale | −1,402 | $90.51 | $127K | 54.1Kdirect | Jun 9, 2023 | Jun 12, 2023 | Form 4 ↗ |
| Zanotti Katherine SDirector | Sale | −3,027 | $90.51 | $274K | 64.6Kdirect | Jun 9, 2023 | Jun 12, 2023 | Form 4 ↗ |
| Herriott JamesGeneral Counsel | Sale | −1,300 | $90.00 | $117K | 7,264direct | Jun 8, 2023 | Jun 12, 2023 | Form 4 ↗ |
| Doyle James EdwardDirector | Sale | −2,000 | $80.62 | $161K | 51.9Kdirect | May 26, 2023 | May 31, 2023 | Form 4 ↗ |
| Condella SarahEVP, Human Resources | Sale | −6,087 | $80.00 | $487K | 80.3Kdirect | May 10, 2023 | May 12, 2023 | Form 4 ↗ |
| ORVILLE JACOB AGeneral Manager, Screening | Sale | −5,000 | $80.00 | $400K | 6,423direct | May 10, 2023 | May 12, 2023 | Form 4 ↗ |
| Herriott JamesGeneral Counsel | Sale | −1,300 | $79.85 | $104K | 8,564direct | May 10, 2023 | May 12, 2023 | Form 4 ↗ |
| Condella SarahEVP, Human Resources | Sale | −1,000 | $63.78 | $64K | 86.4Kdirect | May 1, 2023 | May 3, 2023 | Form 4 ↗ |
| Condella SarahEVP, Human Resources | Sale | −1,000 | $67.19 | $67K | 86.7Kdirect | Apr 3, 2023 | Apr 5, 2023 | Form 4 ↗ |
| ORVILLE JACOB AGeneral Manager, Screening | Sale | −5,000 | $65.00 | $325K | 11.4Kdirect | Mar 3, 2023 | Mar 7, 2023 | Form 4 ↗ |
| Cunningham EverettChief Commercial Officer | Sale | −3,628 | $62.01 | $225K | 22.7Kdirect | Mar 1, 2023 | Mar 2, 2023 | Form 4 ↗ |
| Condella SarahEVP, Human Resources | Sale | −1,000 | $62.00 | $62K | 87.7Kdirect | Mar 1, 2023 | Mar 2, 2023 | Form 4 ↗ |
| Elliott Jeffrey ThomasChief Financial Officer | Sale | −4,233 | $61.12 | $259K | 29.2Kdirect | Feb 28, 2023 | Mar 1, 2023 | Form 4 ↗ |
| Herriott JamesGeneral Counsel | Sale | −875 | $61.12 | $53K | 9,224direct | Feb 28, 2023 | Mar 1, 2023 | Form 4 ↗ |
| Herriott JamesGeneral Counsel | Sale | −1,350 | $59.98 | $81K | 10.1Kdirect | Feb 28, 2023 | Mar 1, 2023 | Form 4 ↗ |
| ORVILLE JACOB AGeneral Manager, Screening | Sale | −1,832 | $61.12 | $112K | 16.4Kdirect | Feb 28, 2023 | Mar 1, 2023 | Form 4 ↗ |
| ORVILLE JACOB AGeneral Manager, Screening | Sale | −5,000 | $59.98 | $300K | 18.3Kdirect | Feb 28, 2023 | Mar 1, 2023 | Form 4 ↗ |
| COWARD D SCOTTDirector | Sale | −4,153 | $61.12 | $254K | 32.8Kdirect | Feb 28, 2023 | Mar 1, 2023 | Form 4 ↗ |
| Condella SarahEVP, Human Resources | Sale | −2,924 | $61.12 | $179K | 88.7Kdirect | Feb 28, 2023 | Mar 1, 2023 | Form 4 ↗ |
| Baranick BrianGen. Mgr., Precision Oncology | Sale | −1,932 | $61.12 | $118K | 7,509direct | Feb 28, 2023 | Mar 1, 2023 | Form 4 ↗ |
| Conroy Kevin TPresident and CEO · Director | Sale | −10.4K | $61.12 | $637K | 1.2Mdirect | Feb 28, 2023 | Mar 1, 2023 | Form 4 ↗ |
| Conroy Kevin TPresident and CEO · Director | Sale | −4,764 | $62.72 | $299K | 1.2Mdirect | Feb 22, 2023 | Feb 23, 2023 | Form 4 ↗ |
| Herriott JamesGeneral Counsel | Sale | −398 | $62.72 | $25K | 9,562direct | Feb 22, 2023 | Feb 23, 2023 | Form 4 ↗ |
| ORVILLE JACOB AGeneral Manager, Screening | Sale | −2,710 | $62.72 | $170K | 19.3Kdirect | Feb 22, 2023 | Feb 23, 2023 | Form 4 ↗ |
| Condella SarahEVP, Human Resources | Sale | −1,033 | $62.72 | $65K | 85.3Kdirect | Feb 22, 2023 | Feb 23, 2023 | Form 4 ↗ |
| COWARD D SCOTTDirector | Sale | −1,007 | $62.72 | $63K | 27.7Kdirect | Feb 22, 2023 | Feb 23, 2023 | Form 4 ↗ |
| Elliott Jeffrey ThomasChief Financial Officer | Sale | −1,430 | $62.72 | $90K | 24.3Kdirect | Feb 22, 2023 | Feb 23, 2023 | Form 4 ↗ |
| Baranick BrianGen. Mgr., Precision Oncology | Sale | −838 | $62.72 | $53K | 5,487direct | Feb 22, 2023 | Feb 23, 2023 | Form 4 ↗ |
| Condella SarahEVP, Human Resources | Sale | −1,076 | $63.91 | $69K | 84.1Kdirect | Feb 16, 2023 | Feb 17, 2023 | Form 4 ↗ |
| Herriott JamesGeneral Counsel | Sale | −400 | $65.59 | $26K | 9,095direct | Feb 15, 2023 | Feb 16, 2023 | Form 4 ↗ |
| Condella SarahEVP, Human Resources | Sale | −954 | $65.59 | $63K | 85.2Kdirect | Feb 15, 2023 | Feb 16, 2023 | Form 4 ↗ |
| ORVILLE JACOB AGeneral Manager, Screening | Sale | −954 | n/c | — | 16.1Kdirect | Feb 15, 2023 | Feb 16, 2023 | Form 4 ↗ |
| COWARD D SCOTTDirector | Sale | −1,821 | $65.59 | $119K | 26.5Kdirect | Feb 15, 2023 | Feb 16, 2023 | Form 4 ↗ |
| Elliott Jeffrey ThomasChief Financial Officer | Sale | −1,866 | $65.59 | $122K | 22.7Kdirect | Feb 15, 2023 | Feb 16, 2023 | Form 4 ↗ |
| Conroy Kevin TPresident and CEO · Director | Sale | −14.6K | $65.59 | $959K | 1.2Mdirect | Feb 15, 2023 | Feb 16, 2023 | Form 4 ↗ |
| Elliott Jeffrey ThomasChief Financial Officer | Sale | −1,158 | $64.55 | $75K | 20.5Kdirect | Feb 13, 2023 | Feb 14, 2023 | Form 4 ↗ |
| Conroy Kevin TPresident and CEO · Director | Sale | −4,527 | $64.55 | $292K | 1.2Mdirect | Feb 13, 2023 | Feb 14, 2023 | Form 4 ↗ |
| Condella SarahEVP, Human Resources | Sale | −1,000 | $67.93 | $68K | 84.1Kdirect | Feb 1, 2023 | Feb 3, 2023 | Form 4 ↗ |
| Condella SarahEVP, Human Resources | Sale | −1,000 | $60.00 | $60K | 85.1Kdirect | Jan 9, 2023 | Jan 11, 2023 | Form 4 ↗ |
| Cunningham EverettChief Commercial Officer | Sale | −16.9K | $31.37 | $529K | 18.7Kdirect | Oct 12, 2022 | Oct 13, 2022 | Form 4 ↗ |
| Baranick BrianGen. Mgr., Precision Oncology | Sale | −984 | $47.12 | $46K | 4,596direct | Aug 5, 2022 | Aug 8, 2022 | Form 4 ↗ |
| Zanotti Katherine SDirector | Sale | −4,608 | $45.14 | $208K | 60.3Kdirect | Jul 26, 2022 | Jul 28, 2022 | Form 4 ↗ |
| Conroy Kevin TPresident and CEO · Director | Sale | −7 | $40.75 | $285 | 1.2Mdirect | Jul 1, 2022 | Jul 6, 2022 | Form 4 ↗ |
| Zanotti Katherine SDirector | Sale | −1,086 | $40.13 | $44K | 60.3Kdirect | Jun 30, 2022 | Jul 1, 2022 | Form 4 ↗ |
| Condella SarahEVP, Human Resources | Sale | −2,816 | $76.69 | $216K | 85.8Kdirect | Mar 1, 2022 | Mar 2, 2022 | Form 4 ↗ |
| Conroy Kevin TPresident and CEO · Director | Sale | −14.3K | $76.69 | $1.1M | 931.0Kdirect | Mar 1, 2022 | Mar 2, 2022 | Form 4 ↗ |
| COWARD D SCOTTChief Legal Officer | Sale | −3,912 | $76.69 | $300K | 16.2Kdirect | Mar 1, 2022 | Mar 2, 2022 | Form 4 ↗ |
| Elliott Jeffrey ThomasChief Financial Officer | Sale | −4,050 | $76.69 | $311K | 19.1Kdirect | Mar 1, 2022 | Mar 2, 2022 | Form 4 ↗ |
| Condella SarahSVP, Human Resources | Sale | −680 | $75.15 | $51K | 82.7Kdirect | Feb 25, 2022 | Mar 1, 2022 | Form 4 ↗ |
| Condella SarahSVP, Human Resources | Sale | −4,800 | $74.05 | $355K | 83.4Kdirect | Feb 25, 2022 | Mar 1, 2022 | Form 4 ↗ |
| Condella SarahSVP, Human Resources | Sale | −4,717 | $70.10 | $331K | 88.2Kdirect | Feb 24, 2022 | Feb 25, 2022 | Form 4 ↗ |
| Conroy Kevin TPresident and CEO · Director | Sale | −27.1K | $70.10 | $1.9M | 915.4Kdirect | Feb 24, 2022 | Feb 25, 2022 | Form 4 ↗ |
| COWARD D SCOTTChief Administrative Officer | Sale | −5,815 | $70.10 | $408K | 11.9Kdirect | Feb 24, 2022 | Feb 25, 2022 | Form 4 ↗ |
| Elliott Jeffrey ThomasChief Financial Officer | Sale | −5,897 | $70.10 | $413K | 14.7Kdirect | Feb 24, 2022 | Feb 25, 2022 | Form 4 ↗ |
| ORVILLE JACOB AGeneral Manager, New Ventures | Sale | −4,717 | $70.10 | $331K | 15.0Kdirect | Feb 24, 2022 | Feb 25, 2022 | Form 4 ↗ |
| Elliott Jeffrey ThomasChief Financial Officer | Sale | −1,557 | $69.05 | $108K | 7,866direct | Feb 23, 2022 | Feb 24, 2022 | Form 4 ↗ |
| Condella SarahSVP, Human Resources | Sale | −1,124 | $69.05 | $78K | 82.7Kdirect | Feb 23, 2022 | Feb 24, 2022 | Form 4 ↗ |
| Conroy Kevin TPresident and CEO · Director | Sale | −5,188 | $69.05 | $358K | 883.9Kdirect | Feb 23, 2022 | Feb 24, 2022 | Form 4 ↗ |
| ORVILLE JACOB AGeneral Manager, New Ventures | Sale | −1,125 | $69.05 | $78K | 9,557direct | Feb 23, 2022 | Feb 24, 2022 | Form 4 ↗ |
| COWARD D SCOTTChief Administrative Officer | Sale | −1,109 | $69.05 | $77K | 4,926direct | Feb 23, 2022 | Feb 24, 2022 | Form 4 ↗ |
| ORVILLE JACOB AGeneral Manager, New Ventures | Sale | −1,749 | $72.72 | $127K | 8,435direct | Feb 22, 2022 | Feb 23, 2022 | Form 4 ↗ |
| Condella SarahSVP, Human Resources | Sale | −938 | $79.55 | $75K | 81.6Kdirect | Feb 15, 2022 | Feb 16, 2022 | Form 4 ↗ |
| Elliott Jeffrey ThomasChief Financial Officer | Sale | −1,839 | $79.55 | $146K | 6,311direct | Feb 15, 2022 | Feb 16, 2022 | Form 4 ↗ |
| Conroy Kevin TPresident and CEO · Director | Sale | −14.4K | $79.55 | $1.1M | 878.7Kdirect | Feb 15, 2022 | Feb 16, 2022 | Form 4 ↗ |
| ORVILLE JACOB AGeneral Manager, New Ventures | Sale | −940 | $79.55 | $75K | 6,535direct | Feb 15, 2022 | Feb 16, 2022 | Form 4 ↗ |
| COWARD D SCOTTChief Administrative Officer | Sale | −1,813 | $79.55 | $144K | 3,788direct | Feb 15, 2022 | Feb 16, 2022 | Form 4 ↗ |
| Conroy Kevin TPresident and CEO · Director | Sale | −16.9K | $93.88 | $1.6M | 664.4Kdirect | Nov 1, 2021 | Nov 3, 2021 | Form 4 ↗ |
| Conroy Kevin TPresident and CEO · Director | Sale | −17.1K | $93.64 | $1.6M | 681.3Kdirect | Oct 1, 2021 | Oct 5, 2021 | Form 4 ↗ |
| Conroy Kevin TPresident and CEO · Director | Sale | −19.0K | $104.42 | $2.0M | 698.4Kdirect | Sep 1, 2021 | Sep 3, 2021 | Form 4 ↗ |
| Conroy Kevin TPresident and CEO · Director | Sale | −20.0K | $107.50 | $2.1M | 717.4Kdirect | Aug 2, 2021 | Aug 4, 2021 | Form 4 ↗ |
| Zanotti Katherine SDirector | Sale Amended | −1,381 | $111.11 | $153K | 34.7Kdirect | Jul 30, 2021 | Aug 3, 2021 | Form 4 ↗ |
| Doyle James EdwardDirector | Sale Amended | −2,640 | $111.17 | $293K | 29.8Kdirect | Jul 30, 2021 | Aug 3, 2021 | Form 4 ↗ |
| Zanotti Katherine SDirector | Sale | −1,381 | $111.11 | $153K | 34.7Kdirect | Jul 30, 2021 | Aug 2, 2021 | Form 4 ↗ |
| Doyle James EdwardDirector | Sale | −2,640 | $111.17 | $293K | 29.8Kdirect | Jul 30, 2021 | Aug 2, 2021 | Form 4 ↗ |
| Elliott Jeffrey ThomasChief Financial Officer | Sale Amended | −1,248 | $114.41 | $143K | 206direct | Jul 29, 2021 | Aug 3, 2021 | Form 4 ↗ |
| Elliott Jeffrey ThomasChief Financial Officer | Sale Amended | −1,899 | $113.35 | $215K | 1,454direct | Jul 29, 2021 | Aug 3, 2021 | Form 4 ↗ |
| Elliott Jeffrey ThomasChief Financial Officer | Sale Amended | −8,675 | $112.39 | $975K | 3,353direct | Jul 29, 2021 | Aug 3, 2021 | Form 4 ↗ |
| Elliott Jeffrey ThomasChief Financial Officer | Sale Amended | −13.9K | $111.58 | $1.5M | 12.0Kdirect | Jul 29, 2021 | Aug 3, 2021 | Form 4 ↗ |
| Elliott Jeffrey ThomasChief Financial Officer | Sale Amended | −7,818 | $110.64 | $865K | 25.9Kdirect | Jul 29, 2021 | Aug 3, 2021 | Form 4 ↗ |
| Elliott Jeffrey ThomasChief Financial Officer | Sale Amended | −2,602 | $109.58 | $285K | 33.7Kdirect | Jul 29, 2021 | Aug 3, 2021 | Form 4 ↗ |
| Elliott Jeffrey ThomasChief Financial Officer | Sale Amended | −1,066 | $108.54 | $116K | 36.3Kdirect | Jul 29, 2021 | Aug 3, 2021 | Form 4 ↗ |
| Elliott Jeffrey ThomasChief Financial Officer | Sale Amended | −1,200 | $107.54 | $129K | 37.4Kdirect | Jul 29, 2021 | Aug 3, 2021 | Form 4 ↗ |
| Elliott Jeffrey ThomasChief Financial Officer | Sale | −1,248 | $114.41 | $143K | 206direct | Jul 29, 2021 | Aug 2, 2021 | Form 4 ↗ |
| Elliott Jeffrey ThomasChief Financial Officer | Sale | −1,899 | $113.35 | $215K | 1,454direct | Jul 29, 2021 | Aug 2, 2021 | Form 4 ↗ |
| Elliott Jeffrey ThomasChief Financial Officer | Sale | −8,675 | $112.39 | $975K | 3,353direct | Jul 29, 2021 | Aug 2, 2021 | Form 4 ↗ |
| Elliott Jeffrey ThomasChief Financial Officer | Sale | −13.9K | $111.58 | $1.5M | 12.0Kdirect | Jul 29, 2021 | Aug 2, 2021 | Form 4 ↗ |
| Elliott Jeffrey ThomasChief Financial Officer | Sale | −7,818 | $110.64 | $865K | 25.9Kdirect | Jul 29, 2021 | Aug 2, 2021 | Form 4 ↗ |
| Elliott Jeffrey ThomasChief Financial Officer | Sale | −2,602 | $109.58 | $285K | 33.7Kdirect | Jul 29, 2021 | Aug 2, 2021 | Form 4 ↗ |
| Elliott Jeffrey ThomasChief Financial Officer | Sale | −1,066 | $108.54 | $116K | 36.3Kdirect | Jul 29, 2021 | Aug 2, 2021 | Form 4 ↗ |
| Elliott Jeffrey ThomasChief Financial Officer | Sale | −1,200 | $107.54 | $129K | 37.4Kdirect | Jul 29, 2021 | Aug 2, 2021 | Form 4 ↗ |
| Conroy Kevin TPresident and CEO · Director | Sale | −7,784 | $123.43 | $961K | 737.3Kdirect | Jul 1, 2021 | Jul 6, 2021 | Form 4 ↗ |
| Condella SarahSVP, Human Resources | Sale Amended | −150 | $124.42 | $19K | 80.5Kdirect | Jun 14, 2021 | Feb 16, 2022 | Form 4 ↗ |
| Condella SarahSVP, Human Resources | Sale Amended | −885 | $123.58 | $109K | 80.6Kdirect | Jun 14, 2021 | Feb 16, 2022 | Form 4 ↗ |
| Condella SarahSVP, Human Resources | Sale Amended | −1,470 | $122.78 | $180K | 81.5Kdirect | Jun 14, 2021 | Feb 16, 2022 | Form 4 ↗ |
| Condella SarahSVP, Human Resources | Sale Amended | −2,945 | $121.88 | $359K | 83.0Kdirect | Jun 14, 2021 | Feb 16, 2022 | Form 4 ↗ |
| Condella SarahSVP, Human Resources | Sale | −1,950 | $120.00 | $234K | 70.9Kdirect | Jun 10, 2021 | Jun 11, 2021 | Form 4 ↗ |
| Condella SarahSVP, Human Resources | Sale | −3,500 | $120.00 | $420K | 70.9Kdirect | Jun 10, 2021 | Jun 11, 2021 | Form 4 ↗ |
| Conroy Kevin TPresident and CEO · Director | Sale | −12.4K | $111.00 | $1.4M | 745.1Kdirect | Jun 1, 2021 | Jun 3, 2021 | Form 4 ↗ |
| Conroy Kevin TPresident and CEO · Director | Sale | −19.2K | $131.09 | $2.5M | 757.5Kdirect | May 3, 2021 | May 5, 2021 | Form 4 ↗ |
| Conroy Kevin TPresident and CEO · Director | Sale | −22.8K | $132.30 | $3.0M | 776.4Kdirect | Apr 1, 2021 | Apr 5, 2021 | Form 4 ↗ |
| LIDGARD GRAHAM PETERChief Science Officer | Sale | −43.2K | $130.00 | $5.6M | 38.4Kdirect | Mar 11, 2021 | Mar 15, 2021 | Form 4 ↗ |
| LIDGARD GRAHAM PETERChief Science Officer | Sale | −11.7K | $121.33 | $1.4M | 33.8Kdirect | Mar 5, 2021 | Mar 8, 2021 | Form 4 ↗ |
| Elliott Jeffrey ThomasChief Financial Officer | Sale | −2,632 | $135.02 | $355K | 38.4Kdirect | Mar 3, 2021 | Mar 5, 2021 | Form 4 ↗ |
| COWARD D SCOTTChief Administrative Officer | Sale | −2,664 | $135.02 | $360K | 1,301direct | Mar 3, 2021 | Mar 5, 2021 | Form 4 ↗ |
| LIDGARD GRAHAM PETERChief Science Officer | Sale | −2,524 | $138.42 | $349K | 45.5Kdirect | Mar 2, 2021 | Mar 3, 2021 | Form 4 ↗ |
| Elliott Jeffrey ThomasChief Financial Officer | Sale | −1,837 | $140.31 | $258K | 41.0Kdirect | Mar 2, 2021 | Mar 3, 2021 | Form 4 ↗ |
| Elliott Jeffrey ThomasChief Financial Officer | Sale | −2,393 | $138.42 | $331K | 42.8Kdirect | Mar 2, 2021 | Mar 3, 2021 | Form 4 ↗ |
| COWARD D SCOTTChief Administrative Officer | Sale | −1,765 | $140.31 | $248K | 3,965direct | Mar 2, 2021 | Mar 3, 2021 | Form 4 ↗ |
| COWARD D SCOTTChief Administrative Officer | Sale | −2,361 | $138.42 | $327K | 5,730direct | Mar 2, 2021 | Mar 3, 2021 | Form 4 ↗ |
| Conroy Kevin TPresident and CEO · Director | Sale | −9,796 | $138.42 | $1.4M | 799.2Kdirect | Mar 2, 2021 | Mar 3, 2021 | Form 4 ↗ |
| Condella SarahSVP, Human Resources | Sale | −1,679 | $138.42 | $232K | 74.1Kdirect | Mar 2, 2021 | Mar 3, 2021 | Form 4 ↗ |
| LIDGARD GRAHAM PETERChief Science Officer | Sale | −1,603 | $137.44 | $220K | 43.0Kdirect | Mar 1, 2021 | Mar 2, 2021 | Form 4 ↗ |
| Elliott Jeffrey ThomasChief Financial Officer | Sale | −6,803 | $136.79 | $931K | 40.2Kdirect | Mar 1, 2021 | Mar 2, 2021 | Form 4 ↗ |
| Elliott Jeffrey ThomasChief Financial Officer | Sale | −1,600 | $137.44 | $220K | 47.0Kdirect | Mar 1, 2021 | Mar 2, 2021 | Form 4 ↗ |
| Condella SarahSVP, Human Resources | Sale | −1,098 | $137.44 | $151K | 72.2Kdirect | Mar 1, 2021 | Mar 2, 2021 | Form 4 ↗ |
| COWARD D SCOTTChief Administrative Officer | Sale | −4,175 | $136.79 | $571K | 3,066direct | Mar 1, 2021 | Mar 2, 2021 | Form 4 ↗ |
| COWARD D SCOTTChief Administrative Officer | Sale | −1,498 | $137.44 | $206K | 3,066direct | Mar 1, 2021 | Mar 2, 2021 | Form 4 ↗ |
| Conroy Kevin TPresident and CEO · Director | Sale | −27.0K | $136.79 | $3.7M | 788.4Kdirect | Mar 1, 2021 | Mar 2, 2021 | Form 4 ↗ |
| Conroy Kevin TPresident and CEO · Director | Sale | −4,335 | $137.44 | $596K | 815.3Kdirect | Mar 1, 2021 | Mar 2, 2021 | Form 4 ↗ |
| WYZGA MICHAEL SDirector | Sale | −19.0K | $130.11 | $2.5M | 2,558direct | Feb 26, 2021 | Mar 2, 2021 | Form 4 ↗ |
| Doyle James EdwardDirector | Sale | −2,000 | $130.11 | $260K | 30.5Kdirect | Feb 26, 2021 | Mar 2, 2021 | Form 4 ↗ |
| COWARD D SCOTTChief Administrative Officer | Sale | −6,788 | $132.96 | $903K | 1,301direct | Feb 25, 2021 | Mar 1, 2021 | Form 4 ↗ |
| LIDGARD GRAHAM PETERChief Science Officer | Sale | −5,842 | $136.30 | $796K | 41.3Kdirect | Feb 24, 2021 | Feb 25, 2021 | Form 4 ↗ |
| Elliott Jeffrey ThomasChief Financial Officer | Sale | −4,449 | $136.30 | $606K | 45.2Kdirect | Feb 24, 2021 | Feb 25, 2021 | Form 4 ↗ |
| COWARD D SCOTTChief Administrative Officer | Sale | −6,062 | $136.30 | $826K | 8,089direct | Feb 24, 2021 | Feb 25, 2021 | Form 4 ↗ |
| Conroy Kevin TPresident and CEO · Director | Sale | −16.4K | $136.30 | $2.2M | 810.4Kdirect | Feb 24, 2021 | Feb 25, 2021 | Form 4 ↗ |
| Condella SarahSVP, Human Resources | Sale | −2,057 | $136.30 | $280K | 70.9Kdirect | Feb 24, 2021 | Feb 25, 2021 | Form 4 ↗ |
| COWARD D SCOTTChief Administrative Officer | Sale | −18.8K | $136.51 | $2.6M | 14.2Kdirect | Feb 23, 2021 | Feb 25, 2021 | Form 4 ↗ |
| ORVILLE JACOB AGeneral Manager, New Ventures | Sale | −1,696 | $143.38 | $243K | 5,445direct | Feb 19, 2021 | Feb 22, 2021 | Form 4 ↗ |
| COWARD D SCOTTChief Administrative Officer | Sale | −1,980 | $140.79 | $279K | 1,301direct | Feb 18, 2021 | Feb 22, 2021 | Form 4 ↗ |
| ORVILLE JACOB AGeneral Manager, New Ventures | Sale | −1,033 | $142.66 | $147K | 3,492direct | Feb 17, 2021 | Feb 18, 2021 | Form 4 ↗ |
| LIDGARD GRAHAM PETERChief Science Officer | Sale | −2,131 | $142.66 | $304K | 35.6Kdirect | Feb 17, 2021 | Feb 18, 2021 | Form 4 ↗ |
| Elliott Jeffrey ThomasChief Financial Officer | Sale | −2,020 | $142.66 | $288K | 40.3Kdirect | Feb 17, 2021 | Feb 18, 2021 | Form 4 ↗ |
| COWARD D SCOTTChief Administrative Officer | Sale | −1,992 | $142.66 | $284K | 3,281direct | Feb 17, 2021 | Feb 18, 2021 | Form 4 ↗ |
| Conroy Kevin TPresident and CEO · Director | Sale | −15.8K | $142.66 | $2.3M | 792.5Kdirect | Feb 17, 2021 | Feb 18, 2021 | Form 4 ↗ |
| Condella SarahSVP, Human Resources | Sale | −1,033 | $142.66 | $147K | 68.7Kdirect | Feb 17, 2021 | Feb 18, 2021 | Form 4 ↗ |
| Conroy Kevin TPresident and CEO · Director | Sale | −30.3K | $138.07 | $4.2M | 759.6Kdirect | Feb 1, 2021 | Feb 3, 2021 | Form 4 ↗ |
| Conroy Kevin TPresident and CEO · Director | Sale | −31.8K | $128.74 | $4.1M | 825.7Kdirect | Jan 4, 2021 | Jan 7, 2021 | Form 4 ↗ |
| Zanotti Katherine SDirector | Sale | −869 | $133.49 | $116K | 21.9Kdirect | Dec 14, 2020 | Dec 14, 2020 | Form 4 ↗ |
| Zanotti Katherine SDirector | Sale | −7,119 | $132.61 | $944K | 22.8Kdirect | Dec 14, 2020 | Dec 14, 2020 | Form 4 ↗ |
| Zanotti Katherine SDirector | Sale | −10.3K | $131.83 | $1.4M | 29.9Kdirect | Dec 14, 2020 | Dec 14, 2020 | Form 4 ↗ |
| Zanotti Katherine SDirector | Sale | −1,736 | $130.44 | $226K | 40.2Kdirect | Dec 14, 2020 | Dec 14, 2020 | Form 4 ↗ |
| Conroy Kevin TPresident and CEO · Director | Sale | −100 | $126.59 | $13K | 857.5Kdirect | Dec 1, 2020 | Dec 2, 2020 | Form 4 ↗ |
| Conroy Kevin TPresident and CEO · Director | Sale | −100 | $126.49 | $13K | 857.6Kdirect | Dec 1, 2020 | Dec 2, 2020 | Form 4 ↗ |
| Conroy Kevin TPresident and CEO · Director | Sale | −7,043 | $125.92 | $887K | 857.7Kdirect | Dec 1, 2020 | Dec 2, 2020 | Form 4 ↗ |
| Conroy Kevin TPresident and CEO · Director | Sale | −10.8K | $124.88 | $1.4M | 864.8Kdirect | Dec 1, 2020 | Dec 2, 2020 | Form 4 ↗ |
| Conroy Kevin TPresident and CEO · Director | Sale | −7,776 | $124.03 | $964K | 875.6Kdirect | Dec 1, 2020 | Dec 2, 2020 | Form 4 ↗ |
| Conroy Kevin TPresident and CEO · Director | Sale | −2,918 | $122.91 | $359K | 883.4Kdirect | Dec 1, 2020 | Dec 2, 2020 | Form 4 ↗ |
| Conroy Kevin TPresident and CEO · Director | Sale | −1,800 | $122.05 | $220K | 886.3Kdirect | Dec 1, 2020 | Dec 2, 2020 | Form 4 ↗ |
| Conroy Kevin TPresident and CEO · Director | Sale | −400 | $124.71 | $50K | 888.1Kdirect | Nov 2, 2020 | Nov 3, 2020 | Form 4 ↗ |
| Conroy Kevin TPresident and CEO · Director | Sale | −600 | $123.45 | $74K | 888.5Kdirect | Nov 2, 2020 | Nov 3, 2020 | Form 4 ↗ |
| Conroy Kevin TPresident and CEO · Director | Sale | −9,577 | $122.33 | $1.2M | 889.1Kdirect | Nov 2, 2020 | Nov 3, 2020 | Form 4 ↗ |
| Conroy Kevin TPresident and CEO · Director | Sale | −10.2K | $121.52 | $1.2M | 898.7Kdirect | Nov 2, 2020 | Nov 3, 2020 | Form 4 ↗ |
| Conroy Kevin TPresident and CEO · Director | Sale | −6,512 | $120.45 | $784K | 908.9Kdirect | Nov 2, 2020 | Nov 3, 2020 | Form 4 ↗ |
| Conroy Kevin TPresident and CEO · Director | Sale | −1,108 | $119.18 | $132K | 915.4Kdirect | Nov 2, 2020 | Nov 3, 2020 | Form 4 ↗ |
| Conroy Kevin TPresident and CEO · Director | Sale | −4,393 | $118.32 | $520K | 916.5Kdirect | Nov 2, 2020 | Nov 3, 2020 | Form 4 ↗ |
| Conroy Kevin TPresident and CEO · Director | Sale | −1,136 | $105.20 | $120K | 920.9Kdirect | Oct 1, 2020 | Oct 2, 2020 | Form 4 ↗ |
| Conroy Kevin TPresident and CEO · Director | Sale | −5,200 | $104.70 | $544K | 922.0Kdirect | Oct 1, 2020 | Oct 2, 2020 | Form 4 ↗ |
| Conroy Kevin TPresident and CEO · Director | Sale | −9,391 | $103.57 | $973K | 927.3Kdirect | Oct 1, 2020 | Oct 2, 2020 | Form 4 ↗ |
| Conroy Kevin TPresident and CEO · Director | Sale | −11.7K | $102.86 | $1.2M | 936.6Kdirect | Oct 1, 2020 | Oct 2, 2020 | Form 4 ↗ |
| Hoof TorstenGeneral Manager, International | Sale | −4,401 | $80.00 | $352K | 2,017direct | Sep 24, 2020 | Sep 28, 2020 | Form 4 ↗ |
| Conroy Kevin TPresident and CEO · Director | Sale | −19.9K | $75.03 | $1.5M | 948.3Kdirect | Sep 1, 2020 | Sep 2, 2020 | Form 4 ↗ |
| Hoof TorstenGeneral Manager, International | Sale | −7,964 | $84.90 | $676K | 2,017direct | Aug 19, 2020 | Aug 21, 2020 | Form 4 ↗ |
| Conroy Kevin TPresident and CEO · Director | Sale | −198 | $95.00 | $19K | 968.3Kdirect | Aug 3, 2020 | Aug 4, 2020 | Form 4 ↗ |
| Conroy Kevin TPresident and CEO · Director | Sale | −25.0K | $93.79 | $2.3M | 968.5Kdirect | Aug 3, 2020 | Aug 4, 2020 | Form 4 ↗ |
| Carey Thomas D.Director | Sale | −30.6K | $94.00 | $2.9M | 21.9Kdirect | Jul 31, 2020 | Aug 4, 2020 | Form 4 ↗ |
| Elliott Jeffrey ThomasChief Financial Officer | Sale | −400 | $97.42 | $39K | 38.4Kdirect | Jul 31, 2020 | Aug 4, 2020 | Form 4 ↗ |
| Elliott Jeffrey ThomasChief Financial Officer | Sale | −5,312 | $95.11 | $505K | 38.8Kdirect | Jul 31, 2020 | Aug 4, 2020 | Form 4 ↗ |
| Elliott Jeffrey ThomasChief Financial Officer | Sale | −15.6K | $94.38 | $1.5M | 44.1Kdirect | Jul 31, 2020 | Aug 4, 2020 | Form 4 ↗ |
| Elliott Jeffrey ThomasChief Financial Officer | Sale | −9,151 | $93.30 | $854K | 59.7Kdirect | Jul 31, 2020 | Aug 4, 2020 | Form 4 ↗ |
| Elliott Jeffrey ThomasChief Financial Officer | Sale | −5,633 | $92.39 | $520K | 68.8Kdirect | Jul 31, 2020 | Aug 4, 2020 | Form 4 ↗ |
| Elliott Jeffrey ThomasChief Financial Officer | Sale | −1,400 | $91.18 | $128K | 74.5Kdirect | Jul 31, 2020 | Aug 4, 2020 | Form 4 ↗ |
| LEVANGIE DANIEL JDirector | Sale | −9,865 | $94.00 | $927K | 15.0Kdirect | Jul 31, 2020 | Aug 4, 2020 | Form 4 ↗ |
| Zanotti Katherine SDirector | Sale | −21.0K | $94.00 | $2.0M | 41.9Kdirect | Jul 31, 2020 | Aug 4, 2020 | Form 4 ↗ |
| Doyle James EdwardDirector | Sale | −2,539 | $94.00 | $239K | 32.5Kdirect | Jul 31, 2020 | Aug 4, 2020 | Form 4 ↗ |
| Elliott Jeffrey ThomasChief Financial Officer | Sale | −8,746 | $95.58 | $836K | 69.2Kdirect | Jul 29, 2020 | Jul 30, 2020 | Form 4 ↗ |
| Zanotti Katherine SDirector | Sale | −1,164 | $96.13 | $112K | 41.9Kdirect | Jul 28, 2020 | Jul 30, 2020 | Form 4 ↗ |
| Stenhouse MarkPresident, Cologuard | Sale | −11.9K | $56.69 | $677K | 29.6Kdirect | Apr 3, 2020 | Apr 6, 2020 | Form 4 ↗ |
| Doyle James EdwardDirector | Sale | −2,000 | $77.54 | $155K | 32.4Kdirect | Feb 28, 2020 | Mar 3, 2020 | Form 4 ↗ |
| Elliott Jeffrey ThomasChief Financial Officer | Sale | −2,383 | $80.17 | $191K | 58.6Kdirect | Feb 28, 2020 | Mar 2, 2020 | Form 4 ↗ |
| Conroy Kevin TPresident and CEO · Director | Sale | −9,750 | $80.17 | $782K | 993.0Kdirect | Feb 28, 2020 | Mar 2, 2020 | Form 4 ↗ |
| Stenhouse MarkPresident, Cologuard | Sale | −1,051 | $80.27 | $84K | 16.5Kdirect | Feb 27, 2020 | Feb 28, 2020 | Form 4 ↗ |
| Elliott Jeffrey ThomasChief Financial Officer | Sale | −1,627 | $80.27 | $131K | 56.1Kdirect | Feb 27, 2020 | Feb 28, 2020 | Form 4 ↗ |
| Conroy Kevin TPresident and CEO · Director | Sale | −13.9K | $80.27 | $1.1M | 982.1Kdirect | Feb 27, 2020 | Feb 28, 2020 | Form 4 ↗ |
| Elliott Jeffrey ThomasChief Financial Officer | Sale | −4,910 | $85.11 | $418K | 54.3Kdirect | Feb 25, 2020 | Feb 26, 2020 | Form 4 ↗ |
| Conroy Kevin TPresident and CEO · Director | Sale | −18.1K | $85.11 | $1.5M | 966.7Kdirect | Feb 25, 2020 | Feb 26, 2020 | Form 4 ↗ |
| Cole G BradleyGeneral Manager - Diagnostics | Sale | −27.4K | $100.00 | $2.7M | 10.2Kdirect | Feb 19, 2020 | Feb 21, 2020 | Form 4 ↗ |
| ORVILLE JACOB AGeneral Manager, New Ventures | Sale | −1,153 | $100.68 | $116K | 2,495direct | Feb 19, 2020 | Feb 20, 2020 | Form 4 ↗ |
| Cole G BradleyGeneral Manager - Diagnostics | Sale | −10.0K | $90.30 | $903K | 8,653direct | Jan 16, 2020 | Jan 17, 2020 | Form 4 ↗ |
| Cole G BradleyGeneral Manager - Diagnostics | Sale | −28.0K | $80.38 | $2.3M | 31.0Kdirect | Nov 21, 2019 | Nov 25, 2019 | Form 4 ↗ |
| Johnson Scott C.SVP - Research and Development | Sale | −3,527 | $108.63 | $383K | 12.3Kdirect | Sep 12, 2019 | Sep 13, 2019 | Form 4 ↗ |
| Zanotti Katherine SDirector | Sale | −1,744 | $117.93 | $206K | 77.5Kdirect | Jul 31, 2019 | Aug 2, 2019 | Form 4 ↗ |
| WYZGA MICHAEL SDirector | Sale | −5,000 | $117.93 | $590K | 8,913direct | Jul 31, 2019 | Aug 2, 2019 | Form 4 ↗ |
| LEVANGIE DANIEL JDirector | Sale | −100 | $120.24 | $12K | 12.5Kdirect | Jul 31, 2019 | Aug 2, 2019 | Form 4 ↗ |
| LEVANGIE DANIEL JDirector | Sale | −8,897 | $119.63 | $1.1M | 12.6Kdirect | Jul 31, 2019 | Aug 2, 2019 | Form 4 ↗ |
| LEVANGIE DANIEL JDirector | Sale | −9,626 | $118.73 | $1.1M | 21.5Kdirect | Jul 31, 2019 | Aug 2, 2019 | Form 4 ↗ |
| LEVANGIE DANIEL JDirector | Sale | −9,572 | $117.72 | $1.1M | 31.1Kdirect | Jul 31, 2019 | Aug 2, 2019 | Form 4 ↗ |
| LEVANGIE DANIEL JDirector | Sale | −2,300 | $116.47 | $268K | 40.7Kdirect | Jul 31, 2019 | Aug 2, 2019 | Form 4 ↗ |
| LEVANGIE DANIEL JDirector | Sale | −9,284 | $115.65 | $1.1M | 43.0Kdirect | Jul 31, 2019 | Aug 2, 2019 | Form 4 ↗ |
| LEVANGIE DANIEL JDirector | Sale | −2,828 | $114.83 | $325K | 52.2Kdirect | Jul 31, 2019 | Aug 2, 2019 | Form 4 ↗ |
| Doyle James EdwardDirector | Sale | −2,808 | $117.93 | $331K | 34.4Kdirect | Jul 31, 2019 | Aug 2, 2019 | Form 4 ↗ |
| Carey Thomas D.Director | Sale | −457 | $120.19 | $55K | 34.2Kdirect | Jul 31, 2019 | Aug 2, 2019 | Form 4 ↗ |
| Carey Thomas D.Director | Sale | −2,770 | $119.30 | $330K | 34.6Kdirect | Jul 31, 2019 | Aug 2, 2019 | Form 4 ↗ |
| Carey Thomas D.Director | Sale | −2,436 | $118.21 | $288K | 37.4Kdirect | Jul 31, 2019 | Aug 2, 2019 | Form 4 ↗ |
| Carey Thomas D.Director | Sale | −1,200 | $117.33 | $141K | 39.8Kdirect | Jul 31, 2019 | Aug 2, 2019 | Form 4 ↗ |
| Carey Thomas D.Director | Sale | −1,800 | $115.89 | $209K | 41.0Kdirect | Jul 31, 2019 | Aug 2, 2019 | Form 4 ↗ |
| Carey Thomas D.Director | Sale | −1,337 | $114.99 | $154K | 42.8Kdirect | Jul 31, 2019 | Aug 2, 2019 | Form 4 ↗ |
| Elliott Jeffrey ThomasChief Financial Officer | Sale | −9,845 | $105.60 | $1.0M | 49.9Kdirect | Jul 30, 2019 | Jul 31, 2019 | Form 4 ↗ |
| Stenhouse MarkPresident, Cologuard | Sale | −11.2K | $92.54 | $1.0M | 14.3Kdirect | Apr 3, 2019 | Apr 4, 2019 | Form 4 ↗ |
| COWARD D SCOTTChief Administrative Officer | Sale | −2,774 | $87.21 | $242K | 103.1Kdirect | Mar 11, 2019 | Mar 12, 2019 | Form 4 ↗ |
| Conroy Kevin TPresident and CEO · Director | Sale | −11.2K | $87.21 | $979K | 938.5Kdirect | Mar 11, 2019 | Mar 12, 2019 | Form 4 ↗ |
| Zanotti Katherine SDirector | Sale | −509 | $96.18 | $49K | 77.1Kdirect | Feb 28, 2019 | Mar 1, 2019 | Form 4 ↗ |
| Zanotti Katherine SDirector | Sale | −800 | $95.09 | $76K | 77.6Kdirect | Feb 28, 2019 | Mar 1, 2019 | Form 4 ↗ |
| Zanotti Katherine SDirector | Sale | −5,461 | $94.31 | $515K | 78.4Kdirect | Feb 28, 2019 | Mar 1, 2019 | Form 4 ↗ |
| Zanotti Katherine SDirector | Sale | −6,102 | $93.45 | $570K | 83.9Kdirect | Feb 28, 2019 | Mar 1, 2019 | Form 4 ↗ |
| Zanotti Katherine SDirector | Sale | −4,300 | $92.33 | $397K | 90.0Kdirect | Feb 28, 2019 | Mar 1, 2019 | Form 4 ↗ |
| Zanotti Katherine SDirector | Sale | −7,828 | $91.08 | $713K | 94.3Kdirect | Feb 28, 2019 | Mar 1, 2019 | Form 4 ↗ |
| WYZGA MICHAEL SDirector | Sale | −500 | $96.00 | $48K | 8,612direct | Feb 28, 2019 | Mar 1, 2019 | Form 4 ↗ |
| Johnson Scott C.SVP - Research and Development | Sale | −1,166 | $93.20 | $109K | 7,652direct | Feb 28, 2019 | Mar 1, 2019 | Form 4 ↗ |
| Elliott Jeffrey ThomasChief Financial Officer | Sale | −2,447 | $93.20 | $228K | 40.6Kdirect | Feb 28, 2019 | Mar 1, 2019 | Form 4 ↗ |
| Doyle James EdwardDirector | Sale | −2,000 | $96.00 | $192K | 35.1Kdirect | Feb 28, 2019 | Mar 1, 2019 | Form 4 ↗ |
| COWARD D SCOTTChief Administrative Officer | Sale | −2,447 | $93.20 | $228K | 99.8Kdirect | Feb 28, 2019 | Mar 1, 2019 | Form 4 ↗ |
| Conroy Kevin TPresident and CEO · Director | Sale | −10.0K | $93.20 | $933K | 925.4Kdirect | Feb 28, 2019 | Mar 1, 2019 | Form 4 ↗ |
| Carey Thomas D.Director | Sale | −7,500 | $96.00 | $720K | 41.5Kdirect | Feb 28, 2019 | Mar 1, 2019 | Form 4 ↗ |
| COWARD D SCOTTChief Administrative Officer | Sale | −9,803 | $95.07 | $932K | 97.3Kdirect | Feb 27, 2019 | Feb 28, 2019 | Form 4 ↗ |
| Conroy Kevin TPresident and CEO · Director | Sale | −9,169 | $95.07 | $872K | 914.8Kdirect | Feb 27, 2019 | Feb 28, 2019 | Form 4 ↗ |
| Elliott Jeffrey ThomasChief Financial Officer | Sale | −4,445 | $90.55 | $402K | 38.1Kdirect | Feb 25, 2019 | Feb 26, 2019 | Form 4 ↗ |
| COWARD D SCOTTChief Administrative Officer | Sale | −6,143 | $90.55 | $556K | 85.7Kdirect | Feb 25, 2019 | Feb 26, 2019 | Form 4 ↗ |
| Conroy Kevin TPresident and CEO · Director | Sale | −16.4K | $90.55 | $1.5M | 903.9Kdirect | Feb 25, 2019 | Feb 26, 2019 | Form 4 ↗ |
| Conroy Kevin TPresident and CEO · Director | Sale | −23.2K | $82.49 | $1.9M | 886.0Kdirect | Jan 25, 2019 | Jan 25, 2019 | Form 4 ↗ |
Source: SEC EDGAR Form 4 and Form 5 filings, SEC's quarterly bulk dataset through Jun 30, 2026, and KeyVex's half-hourly read of new filings since. Every row links its filing. Amendments are marked. Nothing here is a recommendation. All insider activity, market-wide →